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Abstract.  The YF//gene encodes a raslike, GTP- 
binding protein that is essential for growth of yeast 
cells. We show here that mutations in the yptl gene 
disrupt transport of carboxypeptidase Y to the vacuole 
in vivo and transport of pro-et-factor to a site of exten- 
sive glycosylation in the Golgi apparatus in vitro. Two 
different yptl mutations result in loss of function of 
the Golgi complex without affecting the activity of the 
endoplasmic reticulum or soluble components required 
for in vitro transport. The function of the mutant 
Golgi apparatus can be restored by preincubation with 
wild-type cytosol. The transport defect observed in 
vitro cannot be overcome by addition of Ca  ++ to the 
reaction mixture. We have also established genetic in- 
teractions between yptl and a subset of the other genes 
required for transport to and through the Golgi ap- 
paratus. 
TP-BINmNG proteins  play diverse  roles  in the cell 
(Bourne,  1986). Despite this diversity  in function, 
they may share  a common mechanism.  Many are 
thought to operate as molecular switches, changing confor- 
rnation depending  on the nucleotide bound. In their GTP- 
bound state, they each interact with a specific cellular com- 
ponent to stimulate  or inhibit  its  function.  Hydrolysis  of 
bound  GTP  to  GDP  (guanosine  5'-diphosphate) I by  the 
binding  protein  curtails  interaction.  Exchange of GTP for 
GDP is often under control of  another protein. This common 
scheme  can  be  used  for  signal  transduction  (Neer  and 
Clapham,  1988), as in the case of Gs, G~ and transducin 
(Stryer and Bourne,  1986), or to coordinate the events of a 
multistage reaction as in the cases of the elongation factors 
(Kaziro,  1978). One  subset  of GTP-binding  proteins  has 
been defined as raslike because all of  the members share sig- 
nificant sequence identity with the mammalian ms proto-on- 
cogene products. While one of  these proteins, the RAS2 pro- 
tein of yeast, has been clearly implicated in regulating the 
function of adenylate cyclase in response to nutrient starva- 
tion, the functions of  the other raslike proteins are less clear. 
We have focused on the function of one specific raslike 
protein of yeast, the product of the YPT/gene. First iden- 
tiffed as an open reading  frame adjacent to the actin gene 
(Gallwitz et al., 1983), the YP'H gene has been shown by in 
vitro mutagenesis and gene replacement to be essential for 
vegetative growth of yeast (Schmitt et al., 1986; Segev and 
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1. Abbreviations  used in this paper: CPY, carboxypeptidase Y; GDP, guano- 
sine 5'-diphosphate;  HSP, high speed (100,000 g) pellet;  HSS, high speed 
(100,000 g) supernatant;  PYC, permeabilized  yeast cells. 
Botstein,  1987). Study of conditional lethal mutants has led 
to two very different hypotheses regarding the function of  the 
YPT/product.  Schmitt et al. (1988) have argued that its pri- 
mary function is the regulation of intracellular calcium lev- 
els. This proposal is based on the finding that a yptl mutant 
strain exhibits increased 45Ca++ uptake and has a growth de- 
fect that can be partially suppressed by high extracellular lev- 
els  of Ca  ++.  Both  Schmitt  et al.  (1988) and Segev et al. 
(1988) have noted a block in the secretion of invertase at an 
early stage of the secretory pathway and an accumulation of 
membrane bounded organelles at the restrictive temperature. 
Schmitt et al. (1988) have interpreted this phenotype to be 
a  secondary  consequence  of the alteration in intracellular 
Ca  ++ concentration,  while Segev et al. (1988) argue that the 
primary role of the Yptl protein  is in vesicular  transport 
through the Golgi complex. Their argument is based on the 
apparent association of the Yptl protein with the Golgi ap- 
paratus in yeast. They also note the presence of  a cross react- 
ing Yptl homologue in the Golgi complex of a mammalian 
cell line. By this proposal, the Yptl protein would play a role 
at an early stage of transport  that is analogous to the role 
shown for the structurally  related  Sec4 protein  at a  later 
stage,  vesicular  transport  from the Golgi  complex  to the 
plasma membrane (Salminen and Novick, 1987; Goud et al., 
1988). 
In this  report,  we investigate the role of the YPT/ gene 
product in the transport of pro-or-factor from the ER to a site 
of outer chain mannose addition in the Golgi apparatus. We 
have used a recently developed in vitro transport assay (Ruo- 
hola et al., 1988) to probe the site of action of the YPT/gene 
product and to clarify the ambiguity regarding the primary 
defect in the yptl mutant. We have also screened for genetic 
interactions between the YPT/gene and other genes that are 
required  for early stages of transport. 
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Genetic Techniques 
Yeast strains used in this study are listed in Table I. Genetic crosses, sporu- 
lation of dipioids, and dissection of tetrads were done as described by Sher- 
man et al. (1974). Transformation of yeast was done by the method of alkali 
cation treatment (Ito et al., 1983).  Growth properties were assessed by rep- 
lica stamping strains onto YPD (1% yeast extract, 2% Bactopeptone, and 2% 
glucose) plates that were then incubated at 250C, 30°C, 340C, and 37°C and 
scored after 24 h. 
GTP Binding 
Lysates were prepared by vortexing cells in the presence of glass beads, fol- 
lowed by addition of SDS to 2% and heating to 100*C for 3 min. Proteins 
were displayed by electrophoresis on 12%  polyacrylamide gels and then 
transferred to nitrocellulose. GTP-binding proteins were revealed by the 
method of Lapetina and Reep (1987). 
Growth Conditions 
Yeast cells used for the preparation of permeabilized yeast cells (PYC); 
3,000  g  supernatant  ($3)  fractions;  high  speed,  100,000  g,  supernatant 
(HSS); and high speed, 100,000 g pellet (HSP) fractions were usually grown 
in YPD medium (1% yeast extract, 2% bactopeptone, and 2% glucose). 
Strains containing high copy plasmids were grown in Wickerham's minimal 
medium under selective conditions; for radiolabeling experiments, sulfate 
salts were replaced by chloride salts and ammonium sulfate was added to 
a final concentration of 100 or 25 #M. Cells grown in minimal medium were 
incubated for approximately one generation at 25°C in YPD medium and 
then used for the preparation of $3  fractions. The growth medium was 
changed by harvesting cells at room temperature in a clinical centrifuge. 
Cell densities were measured in a 1-cm quartz cuvette at 599 nm in a spec- 
trophotometer (4054  UV/Visible Biochrom Ultrospec Plus; LKB Instru- 
ments Inc., Bromma, Sweden). 
In Vitro Transport Assay 
Prepro-c~-factor  was transcribed and translated (Ruohola et al.,  1988) by a 
modification of the procedure used by Hansen et al. (1986).  Yeast lysates 
containing [32S]methionine  labeled prepro-c~-factor  were used immediately 
after translation or frozen at -80°C. The transport assay was performed in 
two stages as described before (Ruohola et al.,  1988).  In the first stage of 
the reaction,  prepro-c~-factor  translated in a  yeast translation lysate was 
translocated into the ER lumen retained within the PYC. Cells, containing 
the ER form of oz-factor, were pelleted, washed once with transport buffer, 
resuspended in the same buffer, and used to perform the second stage of the 
reaction. At the end of this reaction, the Golgi form of c~-factor resides out- 
side the PYC. To separate the reaction product from the PYC, the cells were 
pelleted during a 23-s centrifugation in a microfuge (Fisher Scientific Co., 
Pittsburgh, PA) and the supernatant was treated with trypsin (470 #g/ml) 
for 20 min at 0°C and then with trypsin inhibitor (940 #g/ml) for 5 rain 
at 0*C. Samples were heated to 100°C in the presence of 1% SDS and c~-fac- 
tor was immunoprecipitated with anti-ct-factor antibody as described before 
Table L Strain List 
NY  15  MATch, ura3-52, his4-619 
NY 45  MATct, ura3-52, sec3-2, yptl-2 
NY 371  MATte, his4-619, pNB142  (SEC4, URA3, 2 #) 
NY 404  MATte, his4-619, sec4-8 
NY 431  MATa, ura3-52, secl8-1 
NY 435*  MATa, ura 3-52, ypt 1-1 
NY 703  MATch, ura3-52, yptl-2 
NY 710  MATt, ura3-52, yptl-2,  pNBI66 (YPT1, URA3, 
CEN4) 
NY 711  MATte, ura3-52, yptl-2, pNB167  (YPT1, 
URA3, 2 #) 
SFNY26-6A  MATs, his4-619 
* DBY 1803 (MATt, ura 3-52, his 4-539, lys 2-801, ypt l-l) was backcrossed 
four times to wild type. 
(Ruohola et al., 1988) or by binding to Con A Sepharose (Sigma Chemical 
Co., St. Louis, MO) in the presence of high salt wash (500 mM NaCI,  1% 
Triton X-100, 20 mM Tris, pH 7.5). When Con A Sepharose was used, sam- 
ples were incubated for 2 h at room temperature in the presence of 90 #1 
of a 20% (vol/vol) solution. The beads were washed twice with 1 ml of low 
salt wash buffer (150 mM NaCI, 1% Triton X-100, 0.1% SDS, 15 mM Tris, 
pH 7.5),  twice with 1 ml of urea wash buffer (2 M urea, 0.2 M NaCI,  1% 
Triton X-100, 0.1 M "Iris, pH 7.5),  once with 1 ml of high salt wash buffer 
and once with 1 ml of Tris-sait buffer (50 mM NaCl, 10 mM "Iris (pH 7.5). 
PYC, $3, HSS, and HSP fractions were prepared as described before (Ruo- 
hola et al.,  1988),  or,  were prepared from regenerated spheroplasts that 
were kept as a packed pellet overnight at 0*C or frozen at -80°C and lysed 
after thawing. To compare the ypt/and sec4 mutants with wild type cells, 
$3 fractions and PYC were assayed at the same protein concentration. The 
protein concentration of each fraction was measured using the Bradford as- 
say (1976) with ovalbumin as a protein standard. Samples were electropho- 
resed in a  12%  SDS polyacrylamide slab gel. 
In Vivo Labeling and lmmunoprecipitation 
Cultures grown overnight at 25°C in minimal medium were supplemented 
with 100 #M ammonium sulfate, 2% glucose, histidine, and uracil. Cells 
(10D599 U) were pelleted, resuspended in 0.5 ml of minimal medium sup- 
plemented with 25 t~M ammonium sulfate, histidine, uracil, and 200 #Ci 
of [35S]sulfate. At the end of a 30-min incubation at 37°C, the cells were 
washed with 1 ml of cold 10-mM sodium azide, converted to spheroplasts 
and lysed as described before (Newman and Ferro-Novick, 1987).  The ly- 
sate was centrifuged at 100,000 g for 1 h in a rotor (Beckman Instruments 
Inc., Palo Alto, CA) and carboxypeptidase Y (CPY) was immunoprecipi- 
tated from the clarified lysate with anti-CPY antibody as described before 
(Newman and Ferro-Novick,  1987). 
Results 
Isolation of a New Allele of  yptl 
A new allele of yptl  was found during a screen of existing 
secretory (sec) mutants for defects in GTP-binding proteins. 
Lysates were prepared from mutants that were grown at 25°C 
in YPD medium, and shifted to 37°C for 1 h. Cellular pro- 
teins were separated by electrophoresis on SDS polyacryl- 
amide gels.  After transfer to nitrocellulose,  GTP-binding 
proteins  were  revealed  by  incubation  of the  filter  with 
[o~32P]GTP and autoradiography. Typically 5 bands are seen 
by this procedure (Goud et al.,  1988).  One strain,  NY45, 
failed to show binding at the position corresponding to the 
Yptl protein (23 kD). Since NY45 carries the sec3-2 muta- 
tion, it was backcrossed to a  wild-type strain,  and tetrads 
were analyzed for linkage of  the sec3-2 growth defect and the 
loss of the Yptl,  GTP-binding band.  The two phenotypes 
were found to be unlinked. Temperature-resistant spores that 
exhibited a  defect in  the  Yptl  band  were  found,  as  were 
temperature-sensitive strains that showed normal binding by 
the Yptl band. The new mutation was tentatively defined as 
yptl-2 and was backcrossed two additional times to a wild- 
type strain.  The yptl-2 mutation, by itself, confers only a 
slight growth defect, which is most apparent in single colony 
growth at 37°C on YPD plates. Therefore, this defect is much 
more  subtle  than  the  previously  isolated yptl-1 mutation 
(Segev and Botstein, 1987) that causes very slow growth at 
intermediate  temperatures,  25-30°C  (grows  at  approxi- 
mately half the rate of wild type at 25°C), and lethality at 
both higher (37°C) and lower temperatures (14°C). 
The identity of the new allele was verified by complemen- 
ration analysis. The mutant was transformed with plasmids 
carrying the wild-type allele of YPT/. The transformants and 
the parental  strain were evaluated on a  GTP-binding blot 
(Fig. 1). The parental yptl-2 strain, NY703, showed no bind- 
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defective for binding GTP. Ly- 
sates  prepared from  various 
strains  were electrophoresed 
on an SDS polyacryamide  gel. 
The protein was transferred to 
nitrocellulose and  incubated 
with ot[32p]GTP. Lane 1, wild 
type; lane 2, yptl-2 (NY703); 
lane 3, yptl-2 with YPT/on a 
CEN vector (NY710); lane 4, 
yptl-2 with  YPT/ on a 2-~m 
vector (NY711); lane 5, sec4-8 
(NY404);  lane  6,  wild  type 
with SEC4 on a 2-~m vector 
(NY371). 
ing in the position of the Yptl protein (Fig. 1, compare lanes 
1 and 2).  The same strain transformed with a  single copy 
number plasmid (pNB166)  showed restored binding (Fig. 1, 
lane 3) and when transformed with a  multi-copy plasmid 
(pNB167)  showed increased binding (Fig. 1, lane 4). There- 
fore, the mutation must be in the yptl gene itself and not in 
a second gene whose product functions to activate the bind- 
ing activity of the Yptl protein. The band above Yptl on the 
blot is the Sec4 protein as shown by its absence in a sec4-8 
strain (Fig. 1, lane 5) and its overproduction in a strain carry- 
ing SEC4 on a multi-copy plasmid (Fig.  1, lane 6). 
The yptl Mutant Blocks Transport to the Vacuole 
In Vivo 
Conditional lethal mutations in the yptl gene disrupt the tran- 
sit of invertase (Segev  et al.,  1988;  Schmitt et al.,  1988). 
This block in export leads to the accumulation of a network 
of ER and an aberrant form of the Golgi apparatus at the re- 
strictive temperature (Schmitt et  al.,  1988;  Segev et al., 
1988).  It was previously shown that the bet and sec ER- 
accumulating secretory mutants block the transport of the 
vacuolar protease CPY (Stevens et al.,  1982; Newman and 
Ferro-Novick,  1987).  CPY follows the early portion of the 
secretory pathway. In the ER, it is glycosylated  at four sites, 
yielding the 67-kD, pl form (Haslik and Tanner,  1978). Sub- 
sequent transport to the Golgi apparatus leads to extension 
of the carbohydrate chains resulting in the 69-kD,  p2 form. 
Just before or upon arrival at the vacuole, an 8-kD NH2 ter- 
minal propeptide is removed, producing the mature form. 
Early blocked secretory mutants arrest transit from the ER 
to the Golgi complex at 37°C, accumulating the pl form of 
CPY (67  kD). 
CPY transport was examined in the conditionally lethal 
yptl-1 allele. Mutant cells were grown at 25°C and then im- 
mediately labeled with [3sS]sulfate upon a  30-min shift to 
the restrictive temperature (37°C). Cells were converted to 
spheroplasts by enzymatic removal of the yeast cell wall, 
lysed with detergent, and CPY was immunoprecipitated with 
anti-CPY antibody. As shown in Fig. 2,  lane 1, wild-type 
cells synthesized the glycosylated, processed, mature form 
of CPY (61 kD); trace amounts ofpl and p2 CPY were also 
detected. In contrast, the yptl-I mutant synthesized a form of 
CPY similar in mobility to the pl form (lane 2). This form 
of CPY was also synthesized in seclS-1 (lane 3), a previously 
identified ER-accumulating mutant (Novick et al.,  1980). 
In some experiments the form of CPY in yptl-1 lysates was 
slightly higher in apparent molecular mass than was the pl 
form in seclS-1 lysates. The significance of this slight shift 
is addressed in the Discussion. Although the yptl-2 strain 
(NY703) is not a conditional lethal mutant, pulse chase ex- 
periments revealed that transit of CPY to the vacuole, as 
measured by the rate of appearance of the mature form, was 
slower than in wild-type cells (not shown). 
A  Defect in the Yptl Protein Disrupts Transport 
In Vitro 
Mutations in the yptl gene disrupt transit through the early 
stage of the secretory pathway in vivo (Segev et al.,  1988; 
Schmitt et al., 1988). To determine whether this defect could 
be reproduced in vitro, we isolated fractions from NY703 
and examined their ability to support transport. 
Transport from the ER to the Golgi complex in vitro can 
be monitored using a gel assay (Ruohola et al.,  1988).  The 
marker  protein  used  in  this  assay  is  a  precursor  to  the 
secreted pheromone or-factor (prepro-ot-factor).  In vivo pre- 
pro-a-factor is synthesized as a 19-kD proprotein that is con- 
verted to a 26-kD polypeptide by the addition of three NH2- 
linked core oligosaccharide units in the lumen of the ER. 
Outer chain carbohydrate, a highly branched structure con- 
sisting of 50-150 mannose residues (Ballou, 1982), is added 
to pro-a-factor in the Golgi complex (Julius et al.,  1984). 
This  modification results  in  a  protein  that  migrates as  a 
higher molecular mass heterogeneous smear on SDS poly- 
acrylamide gels.  In the assay we developed,  transport  is 
monitored by following the processing of  pro-or-factor. In the 
first stage of  this two stage assay, in vitro translated prepro-ot- 
factor enters PYC and is translocated across the lumen of the 
ER where it is glycosylated (26-kD polypeptide). In the sec- 
ond stage,  the ER form of or-factor is converted to the high 
molecular mass Golgi form. Conversion to the Golgi form 
is dependent upon the presence of ATP and the supernatant 
of a yeast lysate spun at 3,000 g ($3 fraction). An advantage 
of our transport assay (Ruohola et al., 1988) is the resolution 
of the membrane components: the ER, or donor compart- 
ment, resides in the permeabilized cells while the acceptor 
Golgi compartment is added exogenously to the cells. At the 
end of the reaction, the high molecular mass Golgi form is 
found outside the PYC with the exogenously added acceptor. 
Fig. 3 A illustrates that an $3 fraction, obtained from the 
yptl-2 mutant, failed to support transport to a site of  extensive 
outer chain addition in vitro when assayed with wild-type 
PYC (Fig. 3, compare lanes 1 and 2 with 3). Although the 
high molecular mass Golgi species was not formed, u-factor 
Figure  2. The ypt/mutant  syn- 
thesizes the pl  form of CPY. 
Newly synthesized CPY was 
labeled with a 30-rain pulse 
of  [35S]methionine at  37"C 
and  was immunoprecipitated 
with anti-CPY antibody. The 
solubilized immunoprecipitates 
were analyzed on a 10% SDS 
polyacrylamide  slab gel: (lane 
1 ) wild type (NY15); (lane 2) 
yptl-1  (NY435);  (lane  3) 
seclS-1 (NY431). 
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transport. A, permeabilized yeast cells (60 #g of protein), contain- 
ing the ER form of c~-factor, were incubated in the absence  (lane 
1) or presence (lane 2) of  a wild-type (SFNY'26-6A) $3 fraction (1.0 
nag of protein).  The yptl-2 mutant (NY703) $3 fraction (1.0 mg of 
protein)  failed to support  transport  (lane 3).  This defect was no 
longer observed when an $3 fraction (1.0 mg of protein) was ob- 
tained from a yptl-2 mutant strain (NY710) harboring a wild-type 
copy of YP//on a CEN plasmid (lane 4). B, yptl-2 PYC (lane 2) 
supported transport as efficiently as wild-type (SFNY26-~) cells 
(lane 1) when assayed in the presence of a wild-type $3 fraction. 
however, mutant HSP failed to support transport when as- 
sayed with a wild-type HSS and wild-type PYC (Fig. 4, com- 
pare lanes 1 and 5).  The yptl-1  allele was also examined in 
the in vitro assay. Fractions from the ypt/-1 mutant were pre- 
pared from cells grown at 25°C and then assayed at 20°C. 
As was the case with ypt/-2, the HSP was the only fraction 
that was found to be defective in the yptl-I lysate (not shown). 
Thus,  mutations in  the Yptl  protein specifically affect the 
Golgi compartment but not the permeabilized cells or the 
soluble factors required for transport. 
In an earlier report (Ruohola et al.,  1988),  we demon- 
strated that, a portion of the 26-kD species and all of the high 
molecular mass Golgi form of a-factor, reside outside the 
PYC at the end of the assay. The released 26-kD species is 
contained within a vesicular reaction intermediate.  Release 
of this intermediate from the permeabilized cells is depen- 
dent upon the presence of ATP (our unpublished  results). 
Fig. 3 shows that when transport is blocked in the yptl-2 mu- 
tant,  a  28-kD  species accumulates.  To determine whether 
this form of t~-factor remains within the cells or is released 
during the reaction,  wild-type cells were incubated with a 
mutant yptl-2 $3 fraction for 90 min at 20°C. Following this 
reaction, the permeabilized cells were pelleted in a micro- 
fuge, and the forms of pro-o~-factor residing in the superna- 
migrating just above the 26-kD species at an approximate ap- 
parent molecular mass of 28 kD was observed. This band is 
not always well resolved from the 26 kD form. If  the $3 frac- 
tion was obtained from a yptl-2 mutant strain that harbored 
a  low copy number,  centromere-based plasmid carrying a 
wild-type copy of  the YPT/gene (pNB166), no defect was ob- 
served (Fig.  3,  lane 4).  This indicated that pNB166  com- 
plemented both the transport defect observed in vitro and the 
GTP-binding defect (Fig.  1), providing additional evidence 
that NY703 harbored a mutation in the ypt/gene and estab- 
lished that the ypt/mutation is responsible for the transport 
defect. The ypt/-2 mutation did not affect the ability of the 
permeabilized cells to support transport, since mutant cells 
were fully functional when assayed in the presence of a wild- 
type $3 fraction (Fig.  3 B, compare lanes 1 and 2).  Thus, 
a defect in the Yptl protein disrupts transit to the site of  exten- 
sive glycosylation in the Golgi complex in vitro and this de- 
fect is associated with the $3 fraction and not with the PYC. 
The Golgi Complex Is Defective in the yptl Mutant 
The $3 fraction can be further subfractionated at 100,000  g 
for 1 h to generate HSS and HSP fractions. The soluble fac- 
tors are provided by the HSS,  while the HSP contains the 
functional Golgi apparatus (Ruohola et al.,  1988). Since the 
function of each compartment can be assayed independently, 
this has enabled us to test the ability ofyptl  mutant fractions 
to support transport in vitro. 
The HSS obtained from the yptl-2  mutant was found to 
support transport when assayed in the presence of wild-type 
HSP and wild-type PYC (Fig. 4,  compare lanes 1 and 4); 
Figure 4. The Golgi complex is defective in the yptl  mutant. The 
$3 fraction from a yptl-2 mutant was defective for transport  when 
assayed with wild-type (SFNY26-6A) PYC (compare lane I  with 
lane 2). This $3 fraction was subfractionated at 100,000 g for 1 h 
to generate  HSS  and  HSP fractions  (lane  3).  The yptl-2  HSS 
efficiently supported transport when assayed with a wild-type HSP 
(compare lanes I and 4); however, the yptl-2 HSP failed to support 
transport  when assayed in the presence of a wild type HSS (lane 
5). Mutant HSS failed to transport the ER form of or-factor  to the 
Golgi complex in the absence of a wild-type HSP and wild-type 
HSS failed to support transport in the absence of a wild-type HSP 
(not shown). The two major bands appearing below the 26-kD spe- 
cies represents partially  core glycosylated pro-a-factor. 
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cells. Wild-type donor cells were incubated with either a yptl-2 (NY 
703) $3 fraction (lanes 1 and 2) or with wild-type (SFNY26-6A) 
cytosol in the presence of a mutant HSP fraction (lane 3). At the 
end of the assay, the samples were centrifuged for 23 s at room tem- 
perature in a microfuge (Fisher Scientific Co.) and processed as de- 
scribed in Materials and Methods.  The forms of a-factor residing 
in the cell pellet and released into the cell supernatant were exam- 
ined by SDS-PAGE. Most of  the 26-kD species and all of the 28-kD 
form of,-factor was released into the supernatant during the reac- 
tion (compare lanes I and 2). The appearance of the 28-kD species 
was dependent upon addition of a HSP fraction that contained the 
mutant Golgi complex  (lane 3).  The 28-kD species was not ob- 
served when the PYC were incubated with mutant HSS and ATP 
(not shown). 
tant and remaining in the cell pellet were examined. We ob- 
served that most of the 26-kD species and all of the 28-kD 
form of a-factor were found in the supernatant (Fig. 5, com- 
pare lanes I  and 2). The formation of the 28-kD species was 
dependent upon addition of a mutant HSP fraction that con- 
tains the yptl Golgi complex (Fig.  5,  lane 3).  This form of 
a-factor was not seen when the PYC were incubated with 
mutant cytosol (not shown).  This finding  suggests that the 
28-kD species is associated with the yptl mutant Golgi frac- 
tion that was added exogenously to the permeabilized cells 
during the assay. 
Fractionation studies have revealed the existence of a solu- 
ble pool of Yptl protein in wild-type cells (Molenaar et al., 
1988). Potentially, the wild-type soluble pool could attach to 
the yptl mutant Golgi apparatus upon preincubation in vitro. 
Fig. 6 (compare lanes I  and 2 with lanes 3 and 4) illustrates 
that the defect in the yptl-2 Golgi compartment was partially 
relieved when the mutant HSP was preincubated with a wild- 
type HSS for 35 min at 20°C in the presence of 1 mM DTT. 
Restoration of transport was not observed when this incuba- 
tion was performed with HSS obtained from the yptl mutant 
(not shown). 
YPT1 and Ca++Regulation 
One proposal regarding the role of the Yptl protein is that 
it functions to regulate intracellular calcium levels. By this 
proposal, the effects of yptl  mutations on protein transport 
are a  secondary consequence of altered intracellular levels 
of calcium. The in vitro transport assay offers a critical test 
of this hypothesis. Because the cytoplasmic space is readily 
accessible during the assay, we can determine whether the 
yptl transport defect can be overcome by the direct addition 
of calcium to the reaction mixture. The assay was performed 
using wild-type permeabilized cells and either a wild-type, 
yptl-1, or yptl-2 mutant $3 fraction. As was previously shown, 
(Fig. 3 A, lane 3 and Fig. 4, lane 2), the mutant $3 fractions 
are defective. The addition of CaCI2, to a  final added con- 
centration of 10/zM, did not restore function to the defective 
fractions, nor did it lower the efficiency of the wild-type reac- 
tion (Fig.  7,  lanes 1, 2,  4,  and 5).  To verify that this level 
of Ca  ++ did  not  interfere with the  assay, the reaction was 
performed in the presence of apyrase, an enzyme that hydro- 
lyses ATE Since the addition of Ca  ++ did not bypass the re- 
quirement for ATP (Fig. 7, lanes 3 and 6), the reaction seen 
in the presence of increased Ca  ++ is authentic. 
The use of calcium/EGTA buffers allows a more accurate 
definition of the free calcium concentration.  Unfortunately 
EGTA causes an inhibition of the assay that cannot be over- 
come by  the  addition  of calcium  (not  shown).  This  may 
reflect the chelation of a trace divalent cation required for the 
assay. A  likely candidate is manganese, since this ion is re- 
quired for the activity of the mannosyl transferases that add 
outer chain carbohydrate (Nakajima and BaUou,  1975).  The 
ER  and  mitochondria  can  take  up  Ca++, and  thus,  when 
Ca  ++ is added  to the transport assay, they can act as Ca  ++ 
sinks.  To try to assess the  free Ca  ++ concentration  during 
the reaction, a mock assay was performed with the addition 
of several concentrations of 4sCa++. Following the reaction, 
the mix was centrifuged at 100,000 g for 1 h and the superna- 
tant was counted. Based on this data we can estimate that the 
addition of 50/zM Ca  ++ to the reaction mixture containing 
an $3 fraction from the yptl-2 mutant, results in a free Ca  ++ 
concentration of at least 6/~M,  and the addition of 10 t,M 
Ca  ++ results in a free concentration of at least 0.9 #M. The 
true level of free Ca  ++ may be somewhat higher as a  result 
Figure 6.  The defect in the yptl mutant can be complemented  in 
vitro. Transport was observed when a wild-type (SFNY26-tA)  $3 
fraction was incubated with wild-type PYC (lane 1). This $3 frac- 
tion was subfractionated into HSS and HSP fractions that were ac- 
tive (lane 2). No activity was seen (lane 3) when the wild-type HSS 
was incubated with the yptl HSP (NY703). However, transport was 
restored if the wild-type HSS was preincubated with the ypt/HSP 
for 35 min at 20°C  in the presence of 1 mM DIT 0ane 4). 
Bacon et al. Yptl Is Required  for Transport In Vitro  1019 Figure 7. CACI2 does not relieve the transport  defect in the yptl 
mutant.  Transport was observed when a wild-type (SFNY26-6A) 
$3 fraction was incubated with wild-type PYC in the absence (lane 
1 ) or the presence (lane 2) of added CaCI2 (10 #M), but not in the 
presence of CaC12 and  apyrase  (lane  3).  Transport  was not ob- 
served when a ypt/-2 (NY703) $3 fraction was incubated with wild- 
type PYC in either  the absence  (lane 4) or presence  (lane 5) of 
added  CaCI2 (10 #M),  or in the presence  of CaCI2 and  apyrase 
(lane 6). 
of Ca  ++  present  in  the  S3  fraction  as  well  as  Ca  ++  con- 
taminating the added water.  Despite this level of free Ca  ++, 
the mutant reaction mixture remains inactive. 
Genetic Interactions between yptl and Early-blocked 
Secretory Mutants 
Previous studies have shown a strong genetic interaction be- 
tween the SEC4 gene and a number of the other SEC genes 
required at a late stage of the secretory pathway (Salminen 
and Novick, 1987). Interaction with SEC4 has been detected 
in two ways. It was first observed that introducing a second 
wild-type copy of SEC4 into a subset of vesicle accumulating 
sec mutants partially suppressed their growth defect. It was 
subsequently shown that double mutants carrying both the 
sec4-8 mutation as well as a temperature-sensitive mutation 
in one of the interacting genes were inviable at all tempera- 
tures,  although the single mutants grew well at 250C.  The 
same set of mutants that were partially suppressed by trans- 
formation with a plasmid carrying the SEC4 gene, were le- 
thal when combined with sec4-8. This set of mutants was re- 
stricted  to vesicle accumulators,  mutants blocked at other 
stages of the secretory pathway showed no interaction. 
The similarity in structure between the Sec4 and Yptl pro- 
teins  suggests that they may function by a  similar mecha- 
nism, but at two distinct stages of the secretory pathway. For 
this reason, one might expect to see interaction of YPT/with 
a subset of the mutants blocked in transport to or through the 
Golgi complex.  We have screened  for  suppression of the 
growth defect of mutants blocked at or before the Golgi ap- 
paratus by overexpression of YPT/. Representative alleles of 
sec and bet mutants were transformed with pNB167, a multi- 
copy plasmid carrying Y/U1. Only a very slight improvement 
in the growth of the sec21-1 strain was seen upon transforma- 
tion. No change in the growth properties of the other mutants 
was detected. 
We next looked for lethality of double mutants.  A yptl-I 
strain  was crossed  to  representatives of each of the  com- 
plementation  groups  of  ER-blocked  (sec12, sec13, sec16, 
sec17, sec18, sec20, sec21, sec22, sec23, bet1, and bet2) and 
Golgi-blocked (sec7and sec14) mutants (Novick et al., 1980; 
Newman and Ferro-Novick,  1987).  Analysis of the tetrads 
revealed that  in crosses to  seven mutants (secT-l, sec12-4, 
sec21-1, sec22-3, sec23-1, bet1-1, and bet2-1), a large number 
of spores failed to give rise to viable colonies. The pattern 
of inviability suggested that in these cases it was the double 
mutants that were inviable (see Table II). The significance of 
this result was somewhat diminished by the fact that the ypt/-1 
single mutant grew quite  slowly at 25°C.  In other words, 
lethality may be caused by the additive effects of two un- 
related partial growth defects rather than by a specific, func- 
tional  interaction  of  two  gene  products.  We  therefore 
repeated this series of crosses using the yptl-2 allele. This al- 
lele shows no detectable growth defect at 25°C,  and is only 
slightly impaired at 37°C.  Lethality of double mutants was 
not  observed  in  crosses  with yptl-2,  yet  in  several  cases 
Table If. Genetic Interactions with YPT1 
Viability of 
yptl-I  double 
mutants,  250C 
Growth  of yptl-2  double  mutants 
25"C  300C  34°C  37°C 
Growth  of single mutants 
25°C  30°C  34°C  37°C 
secT-I  Inviable  +  +  - 
sec12-4  Inviable  +  -  - 
secl4-3  Viable  +  +  - 
sec13-1  Viable  +  -  - 
secl6-2  Viable  +  -  - 
secl 7-1  Viable  +  +  - 
secl8-1  Viable  +  -  - 
sec20-1  Viable  +  -  - 
sec21-1  Inviable  +  -  - 
sec22-3  Inviable  +  -  - 
sec23-1  Inviable  +  -  - 
bet1-1  Inviable  +  -  - 
bet2-1  Inviable  -/+  -  - 
w 
D 
w 
I 
m 
+  +  + 
÷  --  __ 
+  +  + 
÷  --  -- 
÷  --  -- 
+  +  -- 
÷  --  -- 
+  +  -- 
÷  --  -- 
+  +  -- 
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cantly reduced from the threshold temperature of the paren- 
tal strain.  Particularly dramatic was the result of the cross 
between yptl-2 and bet2-1. Both of these mutations confer lit- 
tle if any growth defect at 25°C, and yet the double mutants 
were nearly inviable at this temperature. Weaker effects were 
seen in the crosses of yptl-2  to sec7-1, secI4-3, sec2I-1, and 
betI-1. In the crosses with sec7-1 and secl4-3, the growth of 
the double mutants  failed at 33.5°C,  while the sec7-1 and 
secl4-3 single mutants failed to grow at 37°C. In the crosses 
with sec21-1 and betl-1, the growth of the double mutants 
failed at 30°C,  while the sec21-1 and beth  single mutants 
were able to grow at 30°C,  though not at 36°C. 
Discussion 
We have used an in vitro assay (Ruohola et al., 1988) to char- 
acterize the role of the  YF//gene product in intracellular 
protein transport in yeast. For our analysis,  we have em- 
ployed two different mutant alleles, yptl-1 (Segev and Bot- 
stein, 1987) and yptl-2.  The yptl-1 allele is a conditional le- 
thal allele that grows poorly at all temperatures (Segev et al., 
1988). A phenotype observed in vitro with this allele could 
conceivably be an indirect consequence of its slow growth. 
In contrast, the yptl-2 allele grows well at all temperatures; 
however, a small but perceptible reduction in growth is ob- 
served on YPD plates at 37°C.  The growth defects ofyptl-1 
and yptl-2 correlate well with the defects seen in the transport 
of CPY to the vacuole in vivo: yptl-1 exhibits a  complete 
block, while yptl-2 exhibits only a slowing of transport. The 
yptl-2 allele is useful for in vitro studies since this mutant dis- 
plays a dramatic block in transport in vitro (Fig. 3 A), and 
yet is not conditional lethal for growth. The finding that a 
particular mutation affects protein transport to a greater de- 
gree in vitro than in vivo suggests that the reaction catalyzed 
by the gene product is relatively more rate limiting in vitro. 
Several lines of evidence suggest that Yptl is required for 
transport between an early stage and a later stage of the Golgi 
apparatus.  The form of pro-a-factor that accumulates in a 
yptl mutant in vitro is intermediate in molecular mass be- 
tween the 26-kD core glycosylated form and the high molec- 
ular weight form that accumulates in the Golgi apparatus. 
Formation of this 28-kD species is dependent upon addition 
of the mutant HSP fraction to the permeabilized cells. This 
finding  suggests  that the  26-kD  form of a-factor may be 
transported to another membrane compartment for conver- 
sion to the 28-103 form. Since it is known that the HSP frac- 
tion contains the functional Golgi apparatus in this reaction 
(Ruohola et al., 1988), a likely candidate is the cis compart- 
ment of the Golgi apparatus. The 28-kD species is found out- 
side the permeabilized cells after the reaction, consistent 
with the hypothesis that pro-a-factor is transported to a com- 
partment that is added exogenously to the cells. The 28-kD 
form of pro-a-factor may represent an intermediate in the 
normal transport reaction since we have observed this spe- 
cies in wild type at early times of transport. It is depleted 
as the reaction continues on to yield the high molecular mass 
form (Bacon and Ferro-Novick, unpublished results).  Our 
studies do not exclude the possibility that Yptl  is also re- 
quired for transport from the ER to the Golgi apparatus. 
Significantly less of the 26-kD form of pro-a-factor is con- 
vetted to the 28-kD  form in  the presence of a yptl-2  $3 
fraction than is converted to the high molecular mass form 
in the presence of a  wild-type $3 fraction. Therefore, the 
yptl-2 defect may lead to a partial block in transport from the 
ER to the Golgi apparatus in addition to a block in transport 
through the Golgi apparatus. 
Although the nature of the modification leading to forma- 
tion of the 28-kD form is not known, the addition of several 
mannose residues to each of the three cores of the 26-kD 
form of pro-a-factor could explain the  shift in molecular 
mass.  The same modification could explain the slight shift 
in molecular mass seen in CPY relative to the ER form; how- 
ever, the larger size of the polypeptide would make the in- 
crease in molecular mass more difficult to detect. A more ap- 
parent shift from the core glycosylated form is seen in the 
case ofinvertase (Segev et al., 1988). Invertase contains 9-10 
core oligosaccharide units; the addition of several mannose 
residues to each core should be readily observed for this 
protein. 
Immunofluorescence studies  with  anti-Yptl  antibody  in 
both yeast and mammalian cells suggest that the Yptl protein 
and its mammalian homologue are primarily associated with 
the Golgi apparatus (Segev et al.,  1988), although fraction- 
ation studies indicate that a soluble pool may exist as well 
(Molenaar et al., 1988). Our in vitro findings (Fig. 4) estab- 
lish that a defect in the Yptl protein leads to a loss of Golgi 
function without affecting the  permeabilized cells  or  the 
soluble factors required for transport. This defect is observed 
with either the yptl-1 or yptl-2 allele. Our findings are there- 
fore consistent  with  the  immunofluorescence localization 
studies. 
Strong genetic interactions have been demonstrated be- 
tween the SEC4 gene and a number of the other genes re- 
quired for vesicular transport from the Golgi complex to the 
cell surface (Salminen and Novick,  1987). Because of the 
close structural similarity of the Sec4 protein with the Yptl 
protein, we have screened for analogous genetic interactions 
between YPT/and genes required for early stages of trans- 
port. In general,  YP/7  does not display as strong a pattern 
of genetic interaction as does SEC4. Overexpression of YPT/ 
does not lead to strong suppression of the growth defects 
resulting  from mutations  in  early  stages  of the  secretory 
pathway, and lethality of  double mutants is only seen with the 
yptl-1  allele  and  not  the  yptl-2  allele.  Nonetheless,  the 
genetic interactions observed may signify a functional inter- 
action of the gene products. The strongest effect is seen with 
bet2-1,  a  mutant blocked in transport from the ER to the 
Golgi apparatus. Since Yptl is required for transport through 
the Golgi apparatus, the interactions seen may reflect the in- 
volvement of the BET2 gene product at this stage of the path- 
way in addition to its demonstrated role in transport from the 
ER to the Golgi apparatus. Alternatively, the genetic interac- 
tion may reflect the involvement of the YPT/gene product in 
transport from the ER in addition to its  role in  transport 
through the Golgi apparatus. 
Our data suggests that the transport defect in the yptl mu- 
tants is probably not a consequence of a failure to correctly 
regulate intracellular calcium levels. Addition of calcium to 
the in vitro assay reaction does not bypass the yptl-2 defect. 
In total, our results are consistent with, though do not defini- 
tively establish, the possibility that the Yptl protein plays a 
direct role in the control of vesicular traffic in the Golgi ap- 
paratus. 
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logue,  GTPTS,  is a potent inhibitor  of vesicular transport 
through  the Golgi apparatus  (Melanfon et al.,  1987).  The 
mammalian homologue of Yptl is a possible target of GTP3,S 
action.  Like other GTP-binding proteins,  Yptl must undergo 
a cycle of binding and hydrolyzing GTP to fufill its function 
(Bourne,  1988). GTPTS would prevent Yptl from returning 
to its GDP-bound conformation, and therefore block the cy- 
cle. Further work will be required to understand  the mecha- 
nism by which Yptl functions  to mediate transport and the 
role that GTP binding and hydrolysis play in this mechanism. 
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